Blood Test for Lung Cancer Detection Shows Promise in Research

Hepatitis B is a viral infection that affects the liver and can cause both acute and chronic disease. The virus is transmitted through contact with infected blood or other body fluids. Laboratory testing plays a crucial role in diagnosing hepatitis B infection, monitoring disease progression, and determining appropriate treatment strategies. Understanding the various hepatitis B tests and what their results mean is essential for proper disease management.

The hepatitis B surface antigen test, known as HBsAg, is the primary screening test for hepatitis B infection. When this test is positive, it indicates that a person is currently infected with the hepatitis B virus. If HBsAg remains positive for more than six months, it suggests a chronic infection. The hepatitis B surface antibody test, or anti-HBs, detects antibodies produced in response to the virus or vaccination. A positive anti-HBs result generally indicates immunity to hepatitis B, either from past infection that has cleared or from successful vaccination. The hepatitis B core antibody test, or anti-HBc, helps distinguish between acute, chronic, and past infections. This test comes in two forms: IgM anti-HBc, which indicates recent or acute infection, and total anti-HBc, which indicates either current or past infection.

Additional tests provide important information about the virus and liver function. The hepatitis B e antigen test, or HBeAg, indicates active viral replication and high infectivity when positive. The corresponding antibody test, anti-HBe, suggests lower levels of viral replication. Hepatitis B viral load testing measures the amount of virus in the blood and helps doctors assess disease activity and treatment effectiveness. Liver function tests, including ALT and AST enzymes, evaluate liver damage and inflammation. Elevated levels of these enzymes indicate liver injury, though they are not specific to hepatitis B alone.

Interpreting hepatitis B test results requires understanding the combination of different markers. For example, a person with positive HBsAg and IgM anti-HBc likely has acute hepatitis B infection, while someone with positive HBsAg, positive total anti-HBc, and negative IgM anti-HBc probably has chronic infection. A person with negative HBsAg, positive anti-HBs, and positive anti-HBc has recovered from past infection and has immunity. Someone with negative HBsAg, positive anti-HBs, and negative anti-HBc has immunity from vaccination. Regular monitoring through these laboratory tests helps healthcare providers make informed decisions about treatment and assess the risk of disease transmission to others.